| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2023 |
Requana Aradas A, Djaboub Y, McCort-Tranchepain I, Hajasova Z, Clémenceau L, Canestrelli C, Mann A, Schulz S, Delaval A, Acher F, Massotte D, Noble F, Marie N. Activation of the mu-delta opioid receptor heteromers blocks morphine rewarding effects. The International Journal of Neuropsychopharmacology. PMID 37343217 DOI: 10.1093/ijnp/pyad032 |
0.01 |
|
| 2022 |
Dasgupta P, Mann A, Polgar WE, Reinscheid RK, Zaveri NT, Schulz S. Attenuated G protein signaling and minimal receptor phosphorylation as a biochemical signature of low side-effect opioid analgesics. Scientific Reports. 12: 7154. PMID 35504962 DOI: 10.1038/s41598-022-11189-6 |
0.01 |
|
| 2021 |
Lu JJ, Polgar WE, Mann A, Dasgupta P, Schulz S, Zaveri NT. Differential In vitro Pharmacological Profiles of Structurally Diverse Nociceptin Receptor Agonists in Activating G-protein and Beta-arrestin Signaling at the Human Nociceptin Opioid Receptor. Molecular Pharmacology. PMID 33958480 DOI: 10.1124/molpharm.120.000076 |
0.01 |
|
| 2021 |
Mann A, Keen AC, Mark H, Dasgupta P, Javitch JA, Canals M, Schulz S, Robert Lane J. New phosphosite-specific antibodies to unravel the role of GRK phosphorylation in dopamine D receptor regulation and signaling. Scientific Reports. 11: 8288. PMID 33859231 DOI: 10.1038/s41598-021-87417-2 |
0.01 |
|
| 2020 |
Mann A, Liebetrau S, Klima M, Dasgupta P, Massotte D, Schulz S. Agonist-induced phosphorylation bar code and differential post-activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies. Scientific Reports. 10: 8585. PMID 32444688 DOI: 10.1038/S41598-020-65589-7 |
0.01 |
|
| 2019 |
Mann A, Moulédous L, Froment C, O'Neill PR, Dasgupta P, Günther T, Brunori G, Kieffer BL, Toll L, Bruchas MR, Zaveri NT, Schulz S. Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists. Science Signaling. 12. PMID 30914485 DOI: 10.1126/Scisignal.Aau8072 |
0.01 |
|
| 2017 |
Mann A, Pelz T, Rennert K, Mosig A, Decker M, Lupp A. Evaluation of HepaRG cells for the assessment of indirect drug-induced hepatotoxicity using INH as a model substance. Human Cell. 30: 267-278. PMID 28527127 DOI: 10.1007/s13577-017-0175-9 |
0.01 |
|
| 2017 |
Günther T, Dasgupta P, Mann A, Miess E, Kliewer A, Fritzwanker S, Steinborn R, Schulz S. Targeting multiple opioid receptors - improved analgesics with reduced side effects? British Journal of Pharmacology. PMID 28378462 DOI: 10.1111/Bph.13809 |
0.01 |
|
| 2015 |
Chen C, Chiu YT, Wu W, Huang P, Mann A, Schulz S, Liu-Chen LY. Determination of sites of U50,488H-promoted phosphorylation of the mouse kappa opioid receptor (KOPR): Disconnect between KOPR phosphorylation and internalization. The Biochemical Journal. PMID 26635353 DOI: 10.1042/Bj20141471 |
0.01 |
|
| 2015 |
Lupp A, Mann A, Heeb A, Kaemmerer D, Sänger J, Evert M, Evert K, Mawrin C, Schulz S. Reassessment of endothelin receptor A expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-8. Peptides. 66: 19-25. PMID 25708416 DOI: 10.1016/J.Peptides.2015.02.005 |
0.01 |
|
| 2015 |
Schulz S, Mann A, Novakhov B, Piggins HD, Lupp A. VPAC2 receptor expression in human normal and neoplastic tissues: evaluation of the novel MAB SP235. Endocrine Connections. 4: 18-26. PMID 25504760 DOI: 10.1530/Ec-14-0051 |
0.01 |
|
| 2015 |
Mann A, Illing S, Miess E, Schulz S. Different mechanisms of homologous and heterologous μ-opioid receptor phosphorylation. British Journal of Pharmacology. 172: 311-6. PMID 24517854 DOI: 10.1111/Bph.12627 |
0.01 |
|
| 2014 |
Illing S, Mann A, Schulz S. Heterologous regulation of agonist-independent μ-opioid receptor phosphorylation by protein kinase C. British Journal of Pharmacology. 171: 1330-40. PMID 24308893 DOI: 10.1111/Bph.12546 |
0.01 |
|
| 2014 |
Mann AM, Hinrichs U, Quigley A. Children's creativity lab: Creating a 'pen of the future Acm International Conference Proceeding Series. 11. DOI: 10.1145/2693787.2693805 |
0.01 |
|
| 2013 |
Petrich A, Mann A, Kliewer A, Nagel F, Strigli A, Märtens JC, Pöll F, Schulz S. Phosphorylation of threonine 333 regulates trafficking of the human sst5 somatostatin receptor. Molecular Endocrinology (Baltimore, Md.). 27: 671-82. PMID 23418396 DOI: 10.1210/Me.2012-1329 |
0.01 |
|
| 2013 |
Just S, Illing S, Trester-Zedlitz M, Lau EK, Kotowski SJ, Miess E, Mann A, Doll C, Trinidad JC, Burlingame AL, von Zastrow M, Schulz S. Differentiation of opioid drug effects by hierarchical multi-site phosphorylation. Molecular Pharmacology. 83: 633-9. PMID 23239825 DOI: 10.1124/Mol.112.082875 |
0.01 |
|
| 2012 |
Kliewer A, Mann A, Petrich A, Pöll F, Schulz S. A transplantable phosphorylation probe for direct assessment of G protein-coupled receptor activation. Plos One. 7: e39458. PMID 22745760 DOI: 10.1371/Journal.Pone.0039458 |
0.01 |
|
| 2011 |
Ruprecht CR, Krarup A, Reynell L, Mann AM, Brandenberg OF, Berlinger L, Abela IA, Regoes RR, Günthard HF, Rusert P, Trkola A. MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1. The Journal of Experimental Medicine. 208: 439-54. PMID 21357743 DOI: 10.1084/jem.20101907 |
0.01 |
|
| 2011 |
Kiser TH, Mann AM, Trujillo TC, Hassell KL. Evaluation of empiric versus nomogram-based direct thrombin inhibitor management in patients with suspected heparin-induced thrombocytopenia. American Journal of Hematology. 86: 267-72. PMID 21328434 DOI: 10.1002/ajh.21955 |
0.01 |
|
| 2009 |
Mann AM, Rusert P, Berlinger L, Kuster H, Günthard HF, Trkola A. HIV sensitivity to neutralization is determined by target and virus producer cell properties. Aids (London, England). 23: 1659-67. PMID 19581791 DOI: 10.1097/QAD.0b013e32832e9408 |
0.01 |
|
| 2007 |
Swingler S, Mann AM, Zhou J, Swingler C, Stevenson M. Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein. Plos Pathogens. 3: 1281-90. PMID 17907802 DOI: 10.1371/journal.ppat.0030134 |
0.01 |
|
| 2007 |
Mann AM, Tighe BJ. Tear analysis and lens-tear interactions. Part I. Protein fingerprinting with microfluidic technology. Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association. 30: 163-73. PMID 17499010 DOI: 10.1016/j.clae.2007.03.006 |
0.01 |
|
| 2003 |
Adams WG, Mann AM, Bauchner H. Use of an electronic medical record improves the quality of urban pediatric primary care. Pediatrics. 111: 626-32. PMID 12612247 DOI: 10.1542/peds.111.3.626 |
0.01 |
|
| 2003 |
Stansfield BW, Hillman SJ, Hazlewood ME, Lawson AM, Mann AM, Loudon IR, Robb JE. Normalisation of gait data in children. Gait & Posture. 17: 81-7. PMID 12535730 DOI: 10.1016/S0966-6362(02)00062-0 |
0.01 |
|
| 2003 |
Mann AM, Chen X, Lozovsky VA, Moore CB. Dissociation dynamics of the Ã2A″ state of vinyl radical Journal of Chemical Physics. 118: 4452-4455. DOI: 10.1063/1.1542878 |
0.01 |
|
| 2002 |
Mann AM, Tighe BJ. The application of counter immunoelectrophoresis (CIE) in ocular protein studies Part II: Kinin activity in the lens wearing eye. Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association. 25: 81-8. PMID 16303481 |
0.01 |
|
| 2002 |
Mann AM, Jones LW, Tighe BJ. The application of counter immunoelectrophoresis (CIE) in ocular protein studies. Part I: time dependent deposition patterns of immunoregulatory proteins on anionic hydrogel contact lenses. Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association. 25: 73-80. PMID 16303480 |
0.01 |
|
| 2002 |
Peach HC, Mann AM, Tighe BJ. Immunoblotting and tear sampling techniques for the study of contact lens-induced variations in tear protein profiles. Advances in Experimental Medicine and Biology. 506: 967-71. PMID 12614019 |
0.01 |
|
| 2002 |
Mann AM, Tighe BJ. The detection of kinin activity in contact lens wear. Advances in Experimental Medicine and Biology. 506: 961-6. PMID 12614018 |
0.01 |
|
| 2002 |
Mann AM, Tighe BJ. The application of counter immunoelectrophoresis (CIE) in ocular protein studies. Part II: Kinin activity in the lens wearing eye Contact Lens and Anterior Eye. 25: 81-88. DOI: 10.1016/S1367-0484(02)00004-8 |
0.01 |
|
| 2002 |
Mann AM, Jones LW, Tighe BJ. The application of counter immunoelectrophoresis (CIE) in ocular protein studies. Part I: Time dependent deposition patterns of immunoregulatory proteins on anionic hydrogel contact lenses Contact Lens and Anterior Eye. 25: 73-80. DOI: 10.1016/S1367-0484(02)00003-6 |
0.01 |
|
| 2001 |
Stansfield BW, Hillman SJ, Hazlewood ME, Lawson AA, Mann AM, Loudon IR, Robb JE. Sagittal joint kinematics, moments, and powers are predominantly characterized by speed of progression, not age, in normal children. Journal of Pediatric Orthopedics. 21: 403-11. PMID 11371829 DOI: 10.1097/00004694-200105000-00027 |
0.01 |
|
| 2001 |
Stansfield BW, Hillman SJ, Hazlewood ME, Lawson AA, Mann AM, Loudon IR, Robb JE. Normalized speed, not age, characterizes ground reaction force patterns in 5-to 12-year-old children walking at self-selected speeds. Journal of Pediatric Orthopedics. 21: 395-402. PMID 11371828 DOI: 10.1097/00004694-200105000-00026 |
0.01 |
|
| 2000 |
Adams WG, Conners WP, Mann AM, Palfrey S. Immunization entry at the point of service improves quality, saves time, and is well-accepted. Pediatrics. 106: 489-92. PMID 10969092 |
0.01 |
|
| 1994 |
Asamoto M, Mann AM, Macatee TL, Cohen SM. Mutations and expression of the p53 gene in rat bladder carcinomas and cell lines. Molecular Carcinogenesis. 9: 236-44. PMID 8148056 DOI: 10.1002/mc.2940090408 |
0.01 |
|
| 1994 |
Asamoto M, Mann AM, Cohen SM. p53 mutation is infrequent and might not give a growth advantage in rat bladder carcinogenesis in vivo. Carcinogenesis. 15: 455-8. PMID 8118928 DOI: 10.1093/carcin/15.3.455 |
0.01 |
|
| 1994 |
Mann AM, Asamoto M, Masui T, Macatee T, Eklund SH, Cohen SM. neu is not involved in N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced bladder carcinoma or 2-amino-4-(5-nitro-2-furyl)thiazole transformation of rat bladder epithelial cells. Cancer Letters. 84: 125-31. PMID 7915641 DOI: 10.1016/0304-3835(94)90366-2 |
0.01 |
|
| 1994 |
Mann AM, Asamoto M, Masui T, Macatee T, Eklund SH, Cohen SM. Neu is not involved in N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide- induced bladder carcinoma or 2-amino-4-(5-nitro-2-furyl)thiazole transformation of rat bladder epithelial cells. Cancer Letters. 84: 7-13. PMID 7915640 DOI: 10.1016/0304-3835(94)90352-2 |
0.01 |
|
| 1993 |
Masui T, Mann AM, Borgeson CD, Garland EM, Okamura T, Fujii H, Pelling JC, Cohen SM. Sequencing analysis of Ha-, Ki-, and N-ras genes in rat urinary bladder tumors induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) and sodium saccharin. Teratogenesis, Carcinogenesis, and Mutagenesis. 13: 225-33. PMID 7905676 DOI: 10.1002/tcm.1770130504 |
0.01 |
|
| 1992 |
Masui T, Mann AM, Macatee TL, Okamura T, Garland EM, Smith RA, Cohen SM. Absence of ras oncogene activation in rat urinary bladder carcinomas induced by N-methyl-N-nitrosourea or N-butyl-N-(4-hydroxybutyl)nitrosamine. Carcinogenesis. 13: 2281-5. PMID 1473235 DOI: 10.1093/carcin/13.12.2281 |
0.01 |
|
| 1992 |
Mann AM, Asamoto M, Chlapowski FJ, Masui T, Macatee TL, Cohen SM. Ras involvement in cells transformed with 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT) in vitro and with N-[4-(5-nitro-2-furyl)-2-thiazoyl]formamide in vivo. Carcinogenesis. 13: 1651-5. PMID 1394851 DOI: 10.1093/carcin/13.9.1651 |
0.01 |
|
| 1991 |
Masui T, Mann AM, Macatee TL, Okamura T, Garland EM, Fujii H, Pelling JC, Cohen SM. H-ras mutations in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and sodium saccharin, sodium ascorbate, or related salts. Cancer Research. 51: 3471-5. PMID 2054786 |
0.01 |
|
| 1991 |
Mann AM, Masui T, Chlapowski FJ, Okamura T, Borgeson CD, Cohen SM. In vitro transformation of rat bladder epithelium by 2-amino-4-(5-nitro-2-furyl)thiazole. Carcinogenesis. 12: 417-22. PMID 2009588 DOI: 10.1093/carcin/12.3.417 |
0.01 |
|
| 1991 |
Mann AM, Stevenson M, Masui T, Borgeson CD, Cohen SM. Transformation of rat bladder epithelial cells by introduction of a single oncogene. Oncogene Research. 6: 65-72. PMID 1847743 |
0.01 |
|
| 1991 |
Masui T, Mann AM, Macatee TL, Garland EM, Okamura T, Smith RA, Cohen SM. Direct DNA sequencing of the rat neu oncogene transmembrane domain reveals no mutation in urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine, N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or N-methyl-N-nitrosourea. Carcinogenesis. 12: 1975-8. PMID 1682063 DOI: 10.1093/carcin/12.10.1975 |
0.01 |
|
| 1991 |
Mann AM, Masui T, Chalapowski FJ, Okamura T, Borgeson CD, Cohen SM. In vitro transformation of rat bladder epitheliun by 2-amino-4-(5-nitro-2-furyl)thiazole Carcinogenesis. 12: 1531. DOI: 10.1093/carcin/12.8.1531 |
0.01 |
|
| 1991 |
Mann AM, Masui T, Chlapowski FJ, Okamura T, Borgeson CD, Cohen SM. Corrigendum: In vitro transformation of rat bladder epithelium by 2-amino-4-(5-nitro-2-furyl)thiazole (Carcinogenesis (1991) 12 (417-422)) Carcinogenesis. 12: 1531. |
0.01 |
|
| 1990 |
Masui T, Mann AM, Garland EM, Okamura T, Johansson PL, Cohen SM. Point mutation in codons 12 and 61 of the Ha-ras gene in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Molecular Carcinogenesis. 3: 210-5. PMID 2206284 |
0.01 |
|
| 1990 |
Stevenson M, Haggerty S, Lamonica C, Mann AM, Meier C, Wasiak A. Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis. Journal of Virology. 64: 3792-803. PMID 1695254 |
0.01 |
|
| 1989 |
Masui T, Mann AM, Garland EM, Cohen SM. Strong promoting activity by uracil on urinary bladder carcinogenesis and a possible inhibitory effect on thyroid tumorigenesis in rats initiated with N-methyl-N-nitrosourea. Carcinogenesis. 10: 1471-4. PMID 2752521 DOI: 10.1093/carcin/10.8.1471 |
0.01 |
|
| 1988 |
Stevenson M, Meier C, Mann AM, Chapman N, Wasiak A. Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS. Cell. 53: 483-96. PMID 2966682 DOI: 10.1016/0092-8674(88)90168-7 |
0.01 |
|
| 1985 |
Mann AM, Darby FJ. Effects of 1,2-dibromoethane on glutathione metabolism in rat liver and kidney. Biochemical Pharmacology. 34: 2827-30. PMID 3896244 DOI: 10.1016/0006-2952(85)90002-4 |
0.01 |
|
| 1977 |
Mann AM, Lundell FW. Further experience in conjoint psychotherapy of marital pairs. Canadian Medical Association Journal. 116: 772-4. PMID 849561 |
0.01 |
|
| 1976 |
Fenton FR, Mann AM. The effectiveness of suicide prevention programs J.Amer.Acad.Psych.Neurol.. 1: 5-11. |
0.01 |
|
| 1976 |
Fenton FR, Mann AM. Screening for suicide potential: current status of risk factors Journal of the American Academy of Psychiatry and Neurology. 1: 99-103. |
0.01 |
|
| 1969 |
Mann AM, Matthews CJ. Utilization of non-professional staff in psychiatric treatment programs. Canadian Medical Association Journal. 100: 948-53. PMID 5772642 |
0.01 |
|
| 1968 |
Mann AM, Dancey TE. Interactional aspects of oral examinations. Canadian Psychiatric Association Journal. 13: 425-31. PMID 5685518 |
0.01 |
|
| 1967 |
Mann AM, Hutchison JL. Manic reaction associated with procarbazine hydrochloride therapy of Hodgkin's disease. Canadian Medical Association Journal. 97: 1350-3. PMID 6061601 |
0.01 |
|
| 1966 |
Mann AM, Gold EM. Psychological sequelae of accidental injury: a medico-legal quagmire. Canadian Medical Association Journal. 95: 1359-63. PMID 5928535 |
0.01 |
|
| 1966 |
Lundell FW, Mann AM. Conjoint psychotherapy of marital pairs. Canadian Medical Association Journal. 94: 542-6. PMID 5904927 |
0.01 |
|
| 1965 |
Henry WD, Mann AM. Diagnosis and treatment of delirium. Canadian Medical Association Journal. 93: 1156-66. PMID 5844423 |
0.01 |
|
| 1963 |
Mann AM, Heseltine GF. The Desmethyl Metabolite of Imipramine (G-35020) in the Treatment of Depression: Further Clinical Experience. Canadian Medical Association Journal. 88: 1102-7. PMID 20327557 |
0.01 |
|
| 1963 |
MANN AM, LAING WA. TRANYLCYPROMINE CEPHALGIA. Canadian Medical Association Journal. 89: 1115-8. PMID 14079136 |
0.01 |
|
| 1963 |
ALDOUS NR, MANN AM. THE PATHOPHYSIOLOGY OF DEPRESSION. Canadian Medical Association Journal. 89: 937-43. PMID 14052978 |
0.01 |
|
| 1962 |
MANN AM. Desmethylimipramine (G-35020) in the treatment of depression, pilot study in a general hospital and outpatient setting. Canadian Medical Association Journal. 86: 495-8. PMID 14469313 |
0.01 |
|
| 1959 |
MANN AM, CATTERSON AG, MACPHERSON AS. Toxicity of imipramine: report on serious side effects and massive overdosage. Canadian Medical Association Journal. 81: 23-8. PMID 13662972 |
0.01 |
|
| 1959 |
MANN AM, MACPHERSON AS. Clinical experience with imipramine (G22355) in the treatment of depression. Canadian Psychiatric Association Journal. 4: 38-47. PMID 13629473 |
0.01 |
|
| 1953 |
MANN AM, WITTKOWER ED. A case of depression with attempted suicide treated at a general hospital. Canadian Medical Association Journal. 68: 381-3. PMID 13032900 |
0.01 |
|
| Hide low-probability matches. |